Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BMS-833923 (XL-139), an orally bioavailable Smoothened antagonist, inhibits BODIPY cyclopamine binding to SMO in a dose-dependent manner (IC50: 21 nM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 46.00 | |
10 mg | In stock | $ 74.00 | |
25 mg | In stock | $ 129.00 | |
50 mg | In stock | $ 208.00 | |
100 mg | In stock | $ 376.00 | |
200 mg | In stock | $ 553.00 | |
500 mg | In stock | $ 878.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 54.00 |
Description | BMS-833923 (XL-139), an orally bioavailable Smoothened antagonist, inhibits BODIPY cyclopamine binding to SMO in a dose-dependent manner (IC50: 21 nM). |
Targets&IC50 | BODIPY:21 nM |
Synonyms | XL-139 |
Molecular Weight | 473.57 |
Formula | C30H27N5O |
CAS No. | 1059734-66-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 88 mg/mL (185.8 mM)
Ethanol: < 1 mg/mL (insoluble or slightly soluble)
H2O: < 1 mg/mL (insoluble or slightly soluble)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BMS-833923 1059734-66-5 Apoptosis GPCR/G Protein Stem Cells Smo Hedgehog/Smoothened Inhibitor inhibit Smoothened XL 139 XL139 BMS 833923 XL-139 BMS833923 inhibitor